Angeli Rampersad

Get to know Dr. Rampersad

Dr. Rampersad is a board-certified Pediatric Hematologist at the Indiana Hemophilia and Thrombosis Center (IHTC). Dr. Rampersad is the co-director of Indiana’s Sickle SAFE Program, and Clinical Assistant Professor at Marian University.

Education & Training

University of the West Indies, Trinidad | M.D.

State University of New York, Downstate Medical Center | Residency

Memorial Sloan Kettering Cancer Center | Pediatric Hematology-Oncology Fellowship

Cornell University | Pediatric Hematology-Oncology Fellowship

Certifications & Licensure

Indiana State Medical License

American Board of Pediatrics, Hematology-Oncology

New York Blood Center Transfusion Medicine

American Board of Pediatrics, General Pediatrics Educational Commission for Foreign Medical Graduates

Societies & Honors

American Society of Pediatric Hematology-Oncology

American Society of Hematology

American Academy of Pediatrics

St. Vincent Foundation Caring Angel Award (2014, 2017)

Indianapolis Monthly Top Doctors Award (2015, 2016, 2017)

Expertise & Special Interests

Sickle cell disease, thalassemia and other hemoglobinopathies

Bleeding disorders with special interest in hemophilia, inhibitor detection and eradication, bone and joint health

Hereditary Hemorrhagic Telangiectasia (HHT)

Hospital Affiliations

St. Vincent Hospital, Indianapolis

St. Vincent Hospital, Carmel

St. Vincent Hospital, Fishers

St. Vincent Seton Specialty Hospital

St. Vincent Heart Center

Indiana University Health Riley Children’s Hospital

Indiana University Health North

Indiana University Health Methodist Hospital

Indiana University Health Saxony Hospital

Indiana University Health Morgan Hospital

Publications

Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients. Haemophilia. 2018 Jul 13. doi: 10.1111/hae.13565. Rampersad AG, Boylan B, Miller CH, Shapiro A.

Non invasive Buccal Swab Antigen Sample and Molecular Testing Provides Extended Antigen typing for Patients with Hemoglobinopathies. J Pediatr. 2014 Nov;165(5):1003-7. Rampersad A, Hampton K, Duncan N, Roberson C, Slayten J, Davisson S, Aronowitz J, Shapiro A.

Pediatric sickle cell disease: past successes and future challenges. Pediatr Res. 2017 Jan;81(1-2):249-258. doi: 10.1038/pr.2016.204. Epub 2016 Oct 5. Review. Meier ER, Rampersad A.

More publications by Dr. Rampersad

A short interview with Dr. Rampersad

What do you like about IHTC and its approach to care?

IHTC care teams are dedicated to providing comprehensive care, work as a cohesive group and are enthusiastic about taking on new challenges—all for the good of the patients we serve.

What inspires you about your work?

The ability to care for a patient with a blood disorder through his lifespan with opportunities to impact that individual, his family and in a wider sphere in the community. It’s not just “health care delivery;” good health enhances your patient’s overall well-being, his outlook on life, his family interactions, happiness and his achievements in the community.

What aspect of your work are you the most passionate about?

There is unlimited opportunity to participate in groundbreaking research to help mold future care practices and guidelines for optimized care of patients with relatively rare disorders. Our specialized field has limited evidence-based guidelines for care of the complex disorders that we manage—so our research really allows IHTC to be a pioneer in these otherwise uncharted waters.

Angeli Rampersad, MD